Clinical Challenge: An Underdiagnosed Cause of Resistant Hypertension
Once thought to be rare, the prevalence of primary aldosteronism is estimated to be 5% to 17%, although the condition remains underdiagnosed.
Diagnosis & Disease Information
Concussions May Lead to Hypertension Later in Life Among Football Players
Researchers sought to assess whether concussion burden during years of active play would be a factor for hypertension later in life.
Blood Pressure Control May Help Mitigate Dementia Risk From Hypertension
Researchers sought to assess the age at which the population attributable fraction of dementia from hypertension would be the highest.
Autism May Be a Risk Factor for Cardiometabolic Diseases, Especially in Youth
Investigators from Texas Tech University searched publication databases for studies evaluating risk for diabetes mellitus, hypertension, dyslipidemia, and atherosclerotic macrovascular disease in the setting of ASD.
Hyperglycemia in Pregnancy Associated With Elevated Blood Pressure in Offspring
A study was conducted to determine the relationship between hyperglycemia in pregnancy and elevated blood pressure in offspring.
Education May Predict Dementia Risk Among Centenarians and Near-Centenarians
In a meta-analysis, researchers estimated the prevalence of dementia in a centenarian and near-centenarian population and identified the risk and protective factors for dementia.
Resistant Hypertension Effectively Treated With Novel Drug
Blocking the endothelin pathway could represent a new mode of action to lower blood pressure in resistant hypertension, according to investigators.
Evidence-Based Medicine: Tracking Fracking, Hypertension During Pregnancy, and Safety of Eye Surgery
Dr. Ehrlich reviews the evidence of 3 recent studies that evaluate the risk of fracking and health outcomes in infants, management of hypertension in pregnancy, and cardiac risk of eye surgery.
Continuing ACE Inhibitors Despite Potassium Change Can Have Benefits
Stopping renin-angiotensin-aldosterone inhibitors after hyperkalemia may offset their potential clinical benefits, according to investigators.
FDA Panel Votes on Tenapanor for Hyperphosphatemia in CKD
For patients who tolerated and remained on therapy, the average treatment effect on serum phosphorus was about -0.7mg/dL.
- Loading...
Loading...
Next post in News
Loading... 
Loading...